Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDR | P35968 | 17/20 | 0.76 |
| ▸ | MAP4K4 | O95819 | 8/20 | 0.56 |
| ▸ | LCK | P06239 | 8/20 | 0.56 |
| ▸ | AXL | P30530 | 8/20 | 0.56 |
| ▸ | MAP4K2 | Q12851 | 8/20 | 0.56 |
| ▸ | MAP4K5 | Q9Y4K4 | 8/20 | 0.56 |
| ▸ | PLK4 | O00444 | 7/20 | 0.56 |
| ▸ | CSNK1G2 | P78368 | 7/20 | 0.56 |
| ▸ | BLK | P51451 | 7/20 | 0.56 |
| ▸ | STK3 | Q13188 | 7/20 | 0.56 |
| ▸ | MINK1 | Q8N4C8 | 7/20 | 0.56 |
| ▸ | SRPK1 | Q96SB4 | 7/20 | 0.56 |
| ▸ | SLK | Q9H2G2 | 7/20 | 0.56 |
| ▸ | CLK4 | Q9HAZ1 | 7/20 | 0.56 |
| ▸ | MKNK2 | Q9HBH9 | 7/20 | 0.56 |
| ▸ | CAMK2B | Q13554 | 6/20 | 0.56 |
| ▸ | HIPK4 | Q8NE63 | 6/20 | 0.56 |
| ▸ | CLK2 | P49760 | 6/20 | 0.56 |
| ▸ | CAMK2G | Q13555 | 6/20 | 0.56 |
| ▸ | CAMK2D | Q13557 | 6/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4722710 | 0.87 | KDR (0.59) | KDRMAP4K4LCKAXLMAP4K2 | |
| SCHEMBL5468985 | 0.87 | KDR (0.59) | KDRMAP4K4LCKAXLMAP4K2 | |
| SCHEMBL3531078 | 0.86 | KDR (1.00) | KDRMAP4K4LCKAXLMAP4K2 | |
| SCHEMBL5477222 | 0.80 | KDR (0.55) | KDRMAP4K4LCKAXLMAP4K2 | |
| SCHEMBL4762288 | 0.79 | KDR (0.75) | KDRMAP4K4LCKAXLMAP4K2 | |
| SCHEMBL28013774 | 0.75 | KDR (0.79) | KDRMAP4K4LCKAXLMAP4K2 | |
| SCHEMBL3530946 | 0.74 | KDR (1.00) | KDRMAP4K4LCKAXLMAP4K2 | |
| SCHEMBL29550161 | 0.72 | KDR (1.00) | KDRMAP4K4LCKAXLMAP4K2 | |
| SCHEMBL17034041 | 0.72 | KDR (1.00) | KDRMAP4K4LCKAXLMAP4K2 | |
| SCHEMBL2472309 | 0.72 | KDR (0.80) | KDRMAP4K4LCKAXLMAP4K2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101336244-A | 9-membered heterobicyclic compounds useful as protein kinase inhibitors | ABBOTT LAB (US) | 2008-12-31 | — | — | CN | disclosed |
| US-20070135387-A1 | Inhibitors of protein kinases | ABBOTT LABORATORIES | 2007-06-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070135387-A1 | Inhibitors of protein kinases | MAP3K20, PACSIN2, MAP4K2 | KDR 2196/4885MAP4K4 31/4885LCK 123/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.